Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...

Brain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...

The FDA granted breakthrough status to Serial CTRS, an AI tool that improves survival predictions in non–small cell lung ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

A breakthrough in bladder cancer treatment is helping to save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...

Q4 2024 Results Conference Call February 4, 2025 8:30 AM ETCompany ParticipantsMiri Segal - CEO, MS-IRMoshe Mizrahy - ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...